Polymerisation of fibrin αC-domains promotes endothelial cell migration and proliferation

Summary

Upon conversion of fibrinogen into fibrin, fibrinogen αC-domains containing the RGD recognition motif form ordered αC polymers. Our previous study revealed that polymerisation of these domains promotes integrin-dependent adhesion and spreading of endothelial cells, as well as integrin-mediated activation of the FAK and ERK1/2 signalling pathways. The major goal of this study was to test the impact of αC-domain polymerisation on endothelial cell migration and proliferation during wound healing, and to clarify the mechanism underlying superior activity of αC polymers toward endothelial cells. In an in vitro wound healing assay, confluent endothelial cell monolayers on tissue culture plates coated with the αC monomer or αC polymers were wounded by scratching and wound closure was monitored by timelapse videomicroscopy. Although the plates were coated with equal amounts of αC species, as confirmed by ELISA, wound closure by the cells occurred much faster on αC polymers, indicating that αC-domain polymerisation promotes cell migration and proliferation. In agreement, endothelial cell proliferation was also more efficient on αC polymers, as revealed by cell proliferation assay. Wound closure on both types of substrates was equally inhibited by the integrin-blocking GRGDSP peptide and a specific antagonist of the ERK1/2 signalling pathway. In contrast, blocking the FAK signaling pathway by a specific antagonist decreased wound closure only on αC polymers. These results indicate that polymerisation of the αC-domains enhances integrin-dependent endothelial cell migration and proliferation mainly through the FAK signalling pathway. Furthermore, clustering of integrin-binding RGD motifs in αC polymers is the major mechanism triggering these events.

Keywords

Fibrinogen/fibrin - endothelial cells - cell migration - cell proliferation - wound healing

• References

• 1 Martinez J, Ferber A, Bach TL. et al. Interaction of fibrin with VE-cadherin. Ann NY Acad Sci 2001; 936: 386-405.
• 2 Cheresh DA, Berliner SA, Vicente V. et al. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-953.
• 3 Charo IF, Nannizzi L, Smith JW. et al. The vitronectin receptor αvβ3 binds fibronectin and acts in concert with α5β1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 1990; 111: 2795-2800.
• 4 Leavesley DI, Schwartz MA, Rosenfeld M. et al. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signalling mechanisms. J Cell Biol 1993; 121: 163-170.
• 5 Clark RA, Tonnesen MG, Gailit J. et al. Transient functional expression of αvβ3 on vascular cells during wound repair. Am J Pathol 1996; 148: 1407-1421.
• 6 Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994; 264: 569-571.
• 7 Belkin AM, Tsurupa G, Zemskov E. et al. Transglutaminase-mediated oligomerisation of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signalling. Blood 2005; 105: 3561-3568.
• 8 Kaijzel EL, Koolwijk P, Van Erck MGM. et al. Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo. J Thromb Haemost 2006; 04: 1975-1981.
• 9 Tsurupa G, Tsonev L, Medved L. Structural organisation of the fibrin(ogen) αC-domain. Biochemistry 2002; 41: 6449-6459.
• 10 Tsurupa G, Hantgan RR, Burton RA. et al. Structure, stability, and interaction of the fibrin(ogen) αC-domains. Biochemistry 2009; 48: 12191-12201.
• 11 Medved L, Weisel JW. on behalf of Fibrinogen and Factor XIII Subcommittee of Scientific Standardisation Committee of International Society on Thrombosis and Haemostasis. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost 2009; 07: 355-359.
• 12 Weisel JW, Medved L. The structure and function of the αC domains of fibrinogen. Ann NY Acad Sci 2001; 936: 312-327.
• 13 Matsuka YV, Medved LV, Migliorini MM. et al. Factor XIIIa-catalysed cross-linking of recombinant αC fragments of human fibrinogen. Biochemistry 1996; 35: 5810-5816.
• 14 Tsurupa G, Mahid A, Veklich Y. et al. Structure, stability, and interaction of fibrin αC-domain polymers. Biochemistry 2011; 50: 8028-8037.
• 15 Tsurupa G, Pechik I, Litvinov RI. et al. On the mechanism of αC polymer formation in fibrin. Biochemistry 2012; 51: 2526-2538.
• 16 Romer LH, McLean N, Turner CE. et al. Tyrosine kinase activity, cytoskeletal organisation, and motility in human vascular endothelial cells. Mol Biol Cell 1994; 05: 349-361.
• 17 Eliceiri BP, Klemke R, Stromblad S. et al. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998; 140: 1255-1263.
• 18 Clark RA. Fibrin and wound healing. Ann NY Acad Sci 2001; 936: 355-367.
• 19 Altieri DC. Regulation of leukocyte-endothelium interaction by fibrinogen. Thromb Haemost 1999; 82: 781-786.
• 20 Ugarova TP, Yakubenko VP. Recognition of fibrinogen by leukocyte integrins. Ann NY Acad Sci 2001; 936: 368-385.
• 21 Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 2003; 102: 4035-4043.
• 22 Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 05: 40-46.
• 23 Petrie RJ, Doyle AD, Yamada KM. Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 2009; 10: 538-549.